Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-08 | BioRestorative Therapies, Inc. | Silva Francisco
(VP of Research and Development) |
P | Common Stock | A | 8308 | $1.13 - $1.25 | $10,228 |
2024-03-18 | BioRestorative Therapies, Inc. | Silva Francisco
(VP of Research and Development) |
F | Common Stock | D | 17193 | $1.39 - $1.39 | $23,898 |
2024-03-18 | BioRestorative Therapies, Inc. | ALSTODT LANCE
(President, CEO, COB) |
F | Common Stock | D | 17633 | $1.39 - $1.39 | $24,509 |
2024-02-08 | BioRestorative Therapies, Inc. | Broadrick Dale
(AtLeastTenPercentOwner) |
P | Common Stock | A | 160000 | $1.25 - $1.32 | $206,022 |
2024-02-07 | BioRestorative Therapies, Inc. | Broadrick Dale
(AtLeastTenPercentOwner) |
P | Common Stock | A | 120000 | $1.34 - $1.38 | $162,254 |
2023-11-27 | BioRestorative Therapies, Inc. | Broadrick Dale
(AtLeastTenPercentOwner) |
S | Common Stock | D | 278 | $1.89 - $1.89 | $525 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |